Ginkgo Bioworks Holdings Inc vs PulteGroup, Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while PulteGroup, Inc. trades at $132.77 (market cap $25.22B). The key difference: PulteGroup, Inc. is far larger — about 49.9× Ginkgo Bioworks Holdings Inc's market cap, and PulteGroup, Inc. pays a 0.79% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | PHM | |
|---|---|---|
Market Cap | $505.73M | $25.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $16.14 | $142.56 |
52-Week Low | $5.48 | $110.11 |
Enterprise Value | $607.68M | $25.64B |
Dividend Yield | — | 0.79% |
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →